SDC3 and neoplasm: To assess the potential clinicopathological relevance of SDC3 expression in ovarian cancer, we analyzed its expression in tumor and control tissues using the online tool TNMplot (https://www.tnmplot.com, accessed on 4 June 2021) [18], which combines public gene expression data on ovarian cancer specimens, ovarian cancer metastases and normal tissue from the GEO, GTEx and TCGA datasets.